Karen Facey
Scientific Advisor in HTA
Drymen, Scotland, United Kingdom · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
Following a career as a statistician in the pharmaceutical industry and medicines regulation, Karen entered the field of Health Technology Assessment (HTA). HTA is a multidisciplinary policy analysis of the medical, social, ethical and economic impacts of the introduction, diffusion and disinvestment of health interventions. Karen is passionate about holistic assessment of the impact of interventions in health systems using robust evidence in a variety of forms to inform accountable decision making. This is not just an academic interest, as a Non Executive Director in a Scottish health board for 8 years Karen was also fully aware of the real-life challenges in setting health care priorities when budgets are limited and efficency pressures increase. She also chaired the government committee that created the new funding formula for the NHS (NRAC). She has a critical eye for value assessment and is an engaging presenter and experienced facilitator. In 2014, Karen was named as one of the top 100 practising scientists in the UK. Specialties: Statistics, Health Technology Assessment (HTA) Health provision Health policy Patient involvement in HTA
Experience
Aug 2025
Feb 2024
Oct 2003
Jan 2018 to Mar 2021
May 2009 to May 2014
Jun 2005 to Jun 2012
Jun 2000 to Sep 2003
Jun 1992 to May 1995
Education
PhD, Interim Analysis in Clinical Trials
1987 to 1991
BSc (Hons) with industrial applications, Statistics
1982 to 1986